Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)

Completed

• Conditions: Infections, Epidemics; Respiratory Syncytial Virus Infections

• Registration Number: NCT01915394
• Lead Sponsor: Ankara University

Brief Summary

The principle purpose of this multicenter trial is to determine the definition, timing and the percentage of nosocomial RSV epidemics throughout Turkey. In addition, secondary purpose of the trial is to determine the prevention strategies of further spread of Respiratory Syncytial Virus (RSV) in the neonatal intensive care unit (NICU).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-07-26
• Study First Submitted QC: 2013-08-01
• Study First Posted: 2013-08-02
• Study Start: 2013-09
• Primary Completion: 2014-05
• Study Completion: 2014-06
• Status Verified: 2015-01
• Last Update Submitted: 2015-01-13
• Last Update Posted: 2015-01-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• Confirmed RSV infection with either RSV-strip test or polymerase chain reaction (PCR).
• Admission to the NICU or hospitalized in the NICU between 1 October 2013 and 01 April 2014.

Exclusion Criteria

• Refused informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospitalized Respiratory Syncytial Virus infected Newborn in the Neonatal Intensive Care Units, and its relation with possible epidemics.	Patients will be followed during hospitalization, with expected average of 3 weeks

Secondary Outcome Measures

Name	Time	Method
Mortality	Patients will be followed during hospitalization, with expected average of 3 weeks	mortality related to RSV infection and epidemics

Trial Locations

Locations (1)

Ankara University School of Medicine, Department of Pediatrics, Division of Neonatology; 🇹🇷 Ankara, Turkey